久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • Allergan scores year-end CGRP nod for migraine med Ubrelvy fiercepharma
    December 31, 2019
    The CGRP migraine prevention field already has three meds from Amgen, Eli Lilly and?Teva vying for market share, and now Allergan has scored the first approval for an oral CGRP to treat migraines as they happen.
  • FDA Approves New Treatment for Adults with Migraine americanpharmaceuticalreview
    December 24, 2019
    The U.S. Food and Drug Administration (FDA) approved Ubrelvy (ubrogepant) tablets for the acute (immediate) treatment of migraine with or without aura ...

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service